Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the safety and efficacy of PEG 3350 for use in nerve repair.


Clinical Trial Description

To demonstrate more rapid and increased return of function by PEG-fusion compared to the best current nerve repair techniques. Neurorrhaphy is not new, being performed now for over 150 years much research has been performed. PEG-Axon fusion on the other hand is relatively new in mammals. Success has already been obtained by two institutions in the rat sciatic nerve transections, demonstrating rapid return of behavioral function4. These however are very controlled injuries and unclear how well these will translate into human studies. For this reason 3 separate clinical studies in increasing order of complexity are proposed. The first study proposed will be PEG fusion in digital nerve lacerations. Two goals will be demonstrated; improved innervation density and improved innervation threshold compared to traditional repair, and complication rate similar or less than traditional repair. This will demonstrate the safety and efficacy of the procedure. ;


Study Design


Related Conditions & MeSH terms

  • Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter
  • Wounds and Injuries

NCT number NCT03236064
Study type Interventional
Source WellSpan Health
Contact Richard C Trevino, MD
Phone 717-812-4090
Email rctrevino@trevino6.com
Status Recruiting
Phase Phase 1
Start date May 2016
Completion date May 2024